Finanzen von Health In Tech Inc (HIT)HITHealth In Tech Inc

Evaluating the bottom line, Health In Tech Inc maintains a gross margin of 48.69%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -42.68%, while the net margin is -31.17%. These profitability ratios, combined with a Return on Equity (ROE) of -21.96%, provide a clear picture of how effectively HIT converts its operational activities into shareholder value.

In the context of the broader market, HIT competes directly with industry leaders such as AURE and XTIA. With a market capitalization of $34.20M, it holds a significant position in the sector. When comparing efficiency, HIT's gross margin of 48.69% stands against AURE's N/A and XTIA's 17.39%. Such benchmarking helps identify whether Health In Tech Inc is trading at a premium or discount relative to its financial performance.

The company has shown a decline in revenue, with Q2 2026 revenue at $8.1 million, down from $9.4 million in Q2 2025. The gross margin has also decreased to 48.69% in Q2 2026 from 77.43% in Q4 2024, indicating deteriorating profitability.